Skip to main content
. 2019 Dec;11(12):5310–5320. doi: 10.21037/jtd.2019.11.58

Table 4. Early clinical outcomes.

Variables Unmatched groups Matched groups
T-RAMIE (N=144) H-RAMIE (N=70) P value T-RAMIE (N=49) H-RAMIE (N=49) P value
30-day mortality 0 1 (1.4) 0.327 0 1 (2.0) 0.317
90-day mortality 1 (0.7) 3 (4.3) 0.104 0 3 (6.1) 0.083
Complications 86 (59.7) 43 (61.4) 0.811 31 (63.3) 31 (63.3) 1.000
Complications (grade ≥3) 15 (10.4) 7 (10.0) 0.925 6 (12.2) 6 (12.2) 1.000
Respiratory complications 15 (10.4) 5 (7.1) 0.440 5 (10.2) 5 (10.2) 1.000
Leakage 9 (6.3) 7 (10.0) 0.328 3 (6.1) 5 (10.2) 0.480
Abdomen-related complications 13 (9.0) 9 (12.9) 0.297 4 (8.2) 7 (14.3) 0.366
   Chyloperitoneum 9 (6.3) 5 (7.1) 4 (8.2) 3 (6.1)
   Jejunostomy site problem 1 (0.7) 2 (2.9) 0 2 (2.9)
   Wound problem 2 (1.4) 0 0 0
   Bleeding 0 1 (1.4) 0 1 (2.0)
   Septic colitis 0 1 (1.4) 0 1 (2.0)
   Colon infarction 1 (0.7) 0 0 0
Length of stay (median, range) 13 days (6–244) 13.5 days (7.0–63.0) 0.908 14 days (8–244) 14 days (7–63) 0.936

T-RAMIE, totally robot-assisted minimally invasive esophagectomy; H-RAMIE, hybrid robot-assisted minimally invasive esophagectomy.